Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Transplantation|March 27, 1996
The effect of (steroid) immunosuppression on skeletal muscle glycogen metabolism in patients after kidney transplantationA Ekstrand, C Schalin-Jäntti, M Löfman, et al.
European Journal of Haematology|February 23, 2007
Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomasP Schütt, J Passon, P Ebeling, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 8, 2000
Effect of calcitriol on bone loss after cardiac or lung transplantationP Sambrook, N K Henderson, A Keogh, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 29, 2000
Fatty acid transport protein-1 mRNA expression in skeletal muscle and in adipose tissue in humansC Binnert, H A Koistinen, G Martin, et al.
Human Genetics|May 1, 1997
Markers for the gene ob and serum leptin levels in human morbid obesityL Oksanen, M Ohman, M Heiman, et al.
Diabetes Care|July 1, 1993
Seven years of remission in a type I diabetic patientV A Koivisto, M Leirisalo-Repo, P Ebeling, et al.
The Journal of Clinical Investigation|October 1, 1993
Mechanism of enhanced insulin sensitivity in athletes. Increased blood flow, muscle glucose transport protein (GLUT-4) concentration, and glycogen synthase activityP Ebeling, R Bourey, L Koranyi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2003
Impact of chemotherapy regimen and hematopoietic growth factor on mobilization and collection of peripheral blood stem cells in cancer patientsM R Nowrousian, S Waschke, P Bojko, et al.
Diabetes, Obesity & Metabolism|February 21, 2008
Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylureaA J Garber, J E Foley, M A Banerji, et al.
Bone Marrow Transplantation|June 20, 2017
An individualised risk-adapted protocol of pre- and post transplant zoledronic acid reduces bone loss after allogeneic stem cell transplantation: results of a phase II prospective trialA Grigg, B Butcher, B Khodr, et al.
Pageof 10